About | Free Trial

Last Update

2016-06-03T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Tom Geimer?

Dr. Tom Geimer

Managing Director

Madeleine Pharmaceuticals

Direct Phone: +61 *********       

Madeleine Pharmaceuticals

Company Description

Madeleine Pharmaceuticals is privately held company located in Adelaide, Australia. Founded in 2009 as a spin out from Hospira, Inc, the company is focussed on the development of peptide therapeutics for cardio-renal diseases. Madeleine Pharmaceutical's... more

Find other employees at this company (12)

Background Information

Employment History

Venture Partner

Heidelberg Innovation

Affiliations

Board Member
BioImage A/S

Senior Partner
Apax Partners LLP

Founder
U3 Pharma AG

Founder
Cettera Pty Ltd

Education

Bachelors degree
molecular biology

Honours degree
Molecular Biology

MBA

London Business School

PhD
veterinary science
Hannover , Germany

PhD
veterinary science
University of Wisconsin at Madison

degree
molecular biology
University of Wisconsin at Madison

honors degree
molecular biology
University of Wisconsin at Madison

Web References (23 Total References)


Tom ...

madeleine-pharma.com [cached]

Tom Geimer Tom is Managing Director of Madeleine Pharmaceuticals. He has held positions in various start-ups, corporate management in Germany and on the stock market in the city of London. Tom was previously a Venture Partner with Heidelberg Innovation following five years as a Senior Partner with Apax. Tom was involved with several of the larger transactions at Apax including three corporate spin-outs. In addition, his extensive network resulted in his securing several proprietary deals including Wilex, Zymogenitics, Metagen, BioImage and Atugen. Tom acted as the primary team member on Genmab which returned over 500% IRR and is one of, if not, the top ranking healthcare transaction in the 25 year history of Apax. He was also founder of U3 Pharma which was subsequently sold to Daiichi Sankyo. In 2008, Tom moved at the invitation of the government to Australia as the Entrepreneur in Residence for Biotechnology in South Australia, co-founded Terra Rossa Capital and subsequently progressed selected opportunities to companies, for example, Madeleine Pharmaceuticals. Tom has a degree in molecular biology (Honors) from University of Wisconsin at Madison and a PhD in veterinary science from Hannover, Germany. He also holds a certification in veterinary anesthesiology from the Cornell University and an MBA from London Business School, where he was an international Rotary Scholar.


Tom ...

madeleine-pharma.com [cached]

Tom Geimer Operations


Team | Madeleine Pharmaceuticals

madeleine-pharma.com [cached]

Tom Geimer -Managing Director

...
Tom is Managing Director of Madeleine. He has held positions in various start-ups, corporate management in Germany and on the stock market in the city of London. Tom was previously a Venture Partner with Heidelberg Innovation following five years as a Senior Partner with Apax.
Tom was involved with several of the larger transactions at Apax including three corporate spin-outs. In addition, his extensive network resulted in his securing several proprietary deals including Wilex, Zymogenitics, Metagen, BioImage and Atugen. Tom acted as the primary team member on Genmab which returned over 500% IRR and is one of, if not, the top ranking healthcare transaction in the 25 year history of Apax. He was also founder of U3 Pharma which was subsequently sold to Daiichi Sankyo.
In 2008, Tom moved at the invitation of the government to Australia as the Entrepreneur in Residence for Biotechnology in South Australia, co-founded Terra Rossa Capital and subsequently progressed selected opportunities to companies, for example, Madeleine.
Tom has a degree in molecular biology (Honors) from University of Wisconsin at Madison and a PhD in veterinary science from Hannover, Germany. He also holds a certification in veterinary anesthesiology from the Cornell University and an MBA from London Business School, where he was an international Rotary Scholar.


The Sage Team - Sage Healthcare

www.sagehealthcare.com [cached]

Tom Geimer

...
Dr. Tom Geimer heads Sage Australia, He has an honors degree in molecular biology and a PhD in veterinary science from University of Wisconsin at Madison. He also holds a certification in veterinary anesthesiology from the Cornell University and an MBA from London Business School, where he was an international Rotary Scholar. Dr. Geimer has held positions in various start-ups, corporate management in Germany and on the stock market in the city of London. Tom was christened into life sciences in the early days in Europe. Moving from corporate finance into private equity, he has a vast network of contemporary relationships throughout the brokerage and banking sectors. Tom joined Heidelberg Innovations (HI) in 2005 after five years as a Senior Partner with Apax Partners Private Equity and as a private Advisor to HI. Tom was involved with several of the larger transactions at Apax including three corporate spin-outs. In addition, his extensive network resulted in his securing several proprietary deals for Apax including Wilex and Atugen. Tom acted as the primary team member on Genmab which returned over 500% IRR and is one of, if not, the top ranking healthcare transaction in the 25 year history of Apax. In 2008, Tom emigrated to Australia where he runs his corporate finance practice. He maintains strong US and European links. He joined The Sage Group in 2009.


News - Sage Healthcare

www.sagehealthcare.com [cached]

Cambridge UK and Clinton USA - December 2009 - The Sage Group is pleased to announce the appointment of two new seasoned Executive Directors - Dr. Tom Geimer in Australia and Dr. Laurence Shaw in Israel.

...
"We are very pleased that Laurence and Tom have joined Sage as Executive Directors.
...
Dr. Tom Geimer has an honors degree in molecular biology and a PhD in veterinary science from University of Wisconsin at Madison. He also holds a certification in veterinary anesthesiology from the Cornell University and an MBA from London Business School, where he was an international Rotary Scholar. Dr. Geimer has held positions in various start-ups, corporate management in Germany and on the stock market in the city of London. As a top rated Excel analyst Tom was christened into life sciences in the early days in Europe. Moving from corporate finance into private equity, he has a vast network of contemporary relationships throughout the brokerage and banking sectors. Tom joined Heidelberg Innovations (HI) in 2005 after five years as a Senior Partner with Apax Partners Private Equity and as a private Advisor to HI. Tom was involved with several of the larger transactions at Apax including three corporate spin-outs. In addition, his extensive network resulted in his securing several proprietary deals for Apax including Wilex and Atugen. Tom acted as the primary team member on Genmab which returned over 500% IRR and is one of, if not, the top ranking healthcare transaction in the 25 year history of Apax. In 2008, Tom emigrated to Australia where he runs his corporate finance practice. He maintains strong US and European links. He joined The Sage Group in 2009.
...
Attn: Tom Geimer Tel: +61 4160 599 75 tom@sagehealthcare.com

Similar Profiles

Other People with this Name

Other people with the name Geimer

Harald Geimer
Strategy&

Silke Geimer
Assenagon Asset Management

Winters Geimer
DCMetroTheaterArts

Sara Geimer
ILMxLAB

Maggie Geimer
OneHourTees.com

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory